MedPath

Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Diabetes Mellitus

Completed
Conditions
Myocardial Infarction
Registration Number
NCT00196235
Lead Sponsor
Deutsches Herzzentrum Muenchen
Brief Summary

The purpose of this study was to evaluate the performance of established and new risk predictors in predicting mortality in post-infarction patients suffering from diabetes mellitus

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
650
Inclusion Criteria

acute myocardial infarction, presence of sinusrhythm

Exclusion Criteria

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Deutsches Herzzentrum Muenchen

🇩🇪

Munich, Germany

1. Medizinische Klinik, Klinikum rechts der Isar

🇩🇪

Munich, Germany

© Copyright 2025. All Rights Reserved by MedPath